Home Uncategorized Critical drug shortage at Apeksha Cancer Hospital
Uncategorized

Critical drug shortage at Apeksha Cancer Hospital

Share
Share

A severe shortage of essential cancer medications at Apeksha Hospital has left patients grappling with uncertainty, as life-saving treatments run dry and prices in the private sector soar.

Patients undergoing chemotherapy at the Apeksha Hospital say several critical drugs have been out of stock for weeks, forcing them to purchase medicines from private pharmacies at unaffordable prices when available.

One such drug, an injection used to stimulate white blood cell production during chemotherapy, reportedly costs around Rs. 16,000 per dose in the private market. But even there, supplies are said to be scarce.

“We’re not just fighting cancer anymore. We’re fighting to access the treatment itself,” a patient told the media, appealing to President Anura Kumara Dissanayake and Health Minister Dr. Nalinda Jayatissa to intervene immediately.

Speaking to Lankadeepa, Hospital Director Dr. Aruna Jayasekara confirmed the shortage and said the Health Ministry had been notified.

“We need several medicines. We’ve informed the authorities and are hopeful of a quick resolution,” he said.

Author

Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles
Uncategorized

Sri Lanka’s overseas migration likely to exceed 300,000 again this year

Sri Lanka’s annual overseas migration is likely to exceed 300,000 people again...

Uncategorized

India’s consistent assistance a model for the Indian Ocean and Indo-Pacific Regions – Lankan Envoy

As India recently announced a US$ 450 million “reconstruction package” for Sri...

Uncategorized

Cyclone relief pushes Sri Lanka’s deficit higher, raising debt concerns

Sri Lanka’s fiscal position has weakened sharply following Parliament’s approval of a...

Uncategorized

Sri Lanka health minister acknowledges testing limitations after contaminated drug deaths

Health Minister Dr. Nalinda Jayatissa has acknowledged that the drug testing process...